Primary prophylactic granulocyte colony-stimulating factor (GCSF) in Gilbert’s disease patients treated with FOLFIRI first line for metastatic colorectal cancer (mCRC): Final results of the FFCD 0604 study.
Thierry Lecomte
Honoraria - Roche
Olivier Bouche
Consultant or Advisory Role - Pfizer; Roche
Alice oden-Gangloff
No relevant relationships to disclose
Karine Le Malicot
No relevant relationships to disclose
Thomas Aparicio
No relevant relationships to disclose
Emmanuel Mitry
Consultant or Advisory Role - Roche
Honoraria - Pfizer; Roche
Laurent Bedenne
Honoraria - Amgen
Research Funding - Chugai Pharma; Pfizer
Gael Deplanque
No relevant relationships to disclose
Julien Volet
Honoraria - Roche
David Tougeron
No relevant relationships to disclose
Franck Bonnetain
No relevant relationships to disclose
Marie Moreau
No relevant relationships to disclose
Etienne Dorval
No relevant relationships to disclose
Marie-Anne Loriot
No relevant relationships to disclose
Pierre Laurent-Puig
Honoraria - Amgen
Come Lepage
No relevant relationships to disclose